7 / 16
Addiction Psychiatry 2018
Journal of Addiction Research & Therapy
ISSN: 2155-6105
Page 51
August 13-14, 2018
Madrid, Spain
8
th
International Conference on
Addiction Psychiatry
M
ethadone & buprenorphine maintenance therapy (MMT &
BMT) are the most common forms of opioid agonist therapy
approved by all major medical and professional organizations
concerned with addiction treatment. Patients on MMT & BMT
are also susceptible to any acute or chronic medical & surgical
problems. There are some misconceptions regarding the pain
management in patients with opioid maintenance therapy
including: maintenance of an opioid agonist (methadone or
buprenorphine) provides analgesia; use of opioids for analgesia
can result in addiction relapse; the additive effects of opioid
analgesics and the opioid agonist therapy can cause respiratory
and central nervous system (CNS) depression; the pain complaint
may be a manipulation of opioid drugs or drug-seeking because
of opioid addiction. And there are some barriers to effective
pain management in patients with opioid maintenance therapy
including: deficiencies in clinician practice; inadequacies
knowledge and skills; systems-related problems; misinformation
about opioid analgesia & tolerance; labeling of aberrant behaviors
(pain relief seeking) as abusive drug seeking. We discussed the
various aspects of acute painmanagement in patients with opioid
maintenance therapy in this lecture.
kheirabadi@bsrc.mui.ac.irAcute pain management in patients with opioid
maintenance therapy
Ghloamreza Kheirabadi
Isfahan University of Medical Sciences, Iran
J Addict Res Ther 2018, Volume 9
DOI: 10.4172/2155-6105-C2-040